Search research articles
Contact Us
Filters
Showing results (1-10 of 43) with videos related to
Page
of 5
Sort By:
Oncoimmunology
|
February 6, 2014
Combining low-dose or metronomic chemotherapy with anticancer vaccines: A therapeutic opportunity for lymphomas
Heng Sheng Sow, Stephen R Mattarollo
Nature Immunology
|
October 21, 2010
A novel axis of innate immunity in cancer
Stephen R Mattarollo, Mark J Smyth
Oncoimmunology
|
March 14, 2013
NKT cell adjuvants in therapeutic vaccines against hematological cancers
Stephen R Mattarollo, Mark J Smyth
Molecular Immunology
|
November 29, 2017
Natural killer cell metabolism
Takumi Kobayashi, Stephen R Mattarollo
Frontiers in Immunology
|
November 8, 2017
Invariant Natural Killer T Cells in Immune Regulation of Blood Cancers: Harnessing Their Potential in Immunotherapies
Pui Yeng Lam, Michael D Nissen, Stephen R Mattarollo
Cancer Immunology, Immunotherapy : CII
|
February 1, 2007
Chemotherapy and zoledronate sensitize solid tumour cells to Vgamma9Vdelta2 T cell cytotoxicity
Stephen R Mattarollo, Tony Kenna, Mie Nieda, et al.
Annual Review of Immunology
|
December 21, 2010
Prevention and treatment of papillomavirus-related cancers through immunization
Ian H Frazer, Graham R Leggatt, Stephen R Mattarollo
Cancer Immunology Research
|
November 18, 2017
β-Adrenergic Signaling Impairs Antitumor CD8<sup>+</sup> T-cell Responses to B-cell Lymphoma Immunotherapy
Michael D Nissen, Erica K Sloan, Stephen R Mattarollo
Journal of Leukocyte Biology
|
May 7, 2014
Immunosuppressive roles of natural killer T (NKT) cells in the skin
Sara J McKee, Stephen R Mattarollo, Graham R Leggatt
Journal of Innate Immunity
|
February 28, 2015
Interleukin-17A Promotes Arginase-1 Production and 2,4-Dinitrochlorobenzene-Induced Acute Hyperinflammation in Human Papillomavirus E7 Oncoprotein-Expressing Skin
Le Son Tran, Deepak Mittal, Stephen R Mattarollo, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 43) with videos related to
Sort By:
Page
of 5
Oncoimmunology
|
February 6, 2014
Combining low-dose or metronomic chemotherapy with anticancer vaccines: A therapeutic opportunity for lymphomas
Heng Sheng Sow, Stephen R Mattarollo
Nature Immunology
|
October 21, 2010
A novel axis of innate immunity in cancer
Stephen R Mattarollo, Mark J Smyth
Oncoimmunology
|
March 14, 2013
NKT cell adjuvants in therapeutic vaccines against hematological cancers
Stephen R Mattarollo, Mark J Smyth
Molecular Immunology
|
November 29, 2017
Natural killer cell metabolism
Takumi Kobayashi, Stephen R Mattarollo
Frontiers in Immunology
|
November 8, 2017
Invariant Natural Killer T Cells in Immune Regulation of Blood Cancers: Harnessing Their Potential in Immunotherapies
Pui Yeng Lam, Michael D Nissen, Stephen R Mattarollo
Cancer Immunology, Immunotherapy : CII
|
February 1, 2007
Chemotherapy and zoledronate sensitize solid tumour cells to Vgamma9Vdelta2 T cell cytotoxicity
Stephen R Mattarollo, Tony Kenna, Mie Nieda, et al.
Annual Review of Immunology
|
December 21, 2010
Prevention and treatment of papillomavirus-related cancers through immunization
Ian H Frazer, Graham R Leggatt, Stephen R Mattarollo
Cancer Immunology Research
|
November 18, 2017
β-Adrenergic Signaling Impairs Antitumor CD8<sup>+</sup> T-cell Responses to B-cell Lymphoma Immunotherapy
Michael D Nissen, Erica K Sloan, Stephen R Mattarollo
Journal of Leukocyte Biology
|
May 7, 2014
Immunosuppressive roles of natural killer T (NKT) cells in the skin
Sara J McKee, Stephen R Mattarollo, Graham R Leggatt
Journal of Innate Immunity
|
February 28, 2015
Interleukin-17A Promotes Arginase-1 Production and 2,4-Dinitrochlorobenzene-Induced Acute Hyperinflammation in Human Papillomavirus E7 Oncoprotein-Expressing Skin
Le Son Tran, Deepak Mittal, Stephen R Mattarollo, et al.
Page
of 5